A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer
Clinical trial NCT07159451 · RECRUITING
Trial details
- NCT number
- NCT07159451
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-06
- Primary completion
- 2027-01-29
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.